Type 2 diabetes drug tirzepatide has been shown to be effective in treating moderate to severe sleep apnoea in a worldwide clinical trial.
US researchers showed that tirzepatide (Mounjaro) — a GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist (RA) — can…
[ad_2]
Source link